Key result
AT1 antagonist GR138950C reduces pulmonary arterial pressure ~25% vs saline in hypoxic rats.
Why the study?
Does AT1 antagonism reduce pulmonary hypertension and cardiac remodeling in a rat model of hypoxia-induced pulmonary hypertension?
Does AT1 antagonism reduce pulmonary hypertension and cardiac remodeling in a rat model of hypoxia-induced pulmonary hypertension?
Answers are grounded in this paper and cite their sources.
AT1 receptor antagonism attenuates the development of hypoxia-induced pulmonary hypertension and right ventricular hypertrophy in a rat model.
Angiotensin II (AII) binding density and the effect of chronic AII receptor blockade were examined in the rat model of hypoxia-induced pulmonary hypertension. 2. [125I]-[Sar1,Ile2]AII binding capacity was increased in lung membranes from rats exposed to hypoxia (10% fractional inspired O2) for 7 days compared to normal rats (Bmax 108 +/- 12 vs 77 +/- 3 fmol mg-1 protein; P < 0.05), with no significant change in dissociation constant. Competition with specific AII receptor subtype antagonists demonstrated that AT1 is the predominant subtype in both normal and hypoxic lung. 3. Rats treated intravenously with the AT1 antagonist, GR138950C, 1 mg kg-1 day-1 rather than saline alone during 7 days of exposure to hypoxia developed less pulmonary hypertension (pulmonary arterial pressure: 21.3 +/- 1.7 vs 28.3 +/- 1.1 mmHg; P < 0.05), right ventricular hypertrophy (right/left ventricle weight ratio: 0.35 +/- 0.01 vs 0.45 +/- 0.01; P < 0.05) and pulmonary artery remodelling (abundance of thick-walled pulmonary vessels: 9.6 +/- 1.4% vs 20.1 +/- 0.9%; P < 0.05). 4. The reduction in cardiac hypertrophy and pulmonary remodelling with the AT1 antagonist was greater than that achieved by a dose of sodium nitroprusside (SNP) that produced a comparable attenuation of the rise in pulmonary arterial pressure during hypoxia. 5. The data suggest that AII, via the AT1 receptor, has a role in the early pathogenesis of hypoxia-induced pulmonary hypertension in the rat.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (1996) studied hypoxia-induced pulmonary hypertension. GR138950C vs. saline was evaluated on pulmonary arterial pressure (mmHg) (p=< 0.05). Treatment with the AT1 antagonist GR138950C during 7 days of hypoxia reduced pulmonary arterial pressure compared to saline in rats.
Synapse has enriched 10 related papers. Consider them for comparative context: